Uncovering the Differences: How DLQI and WHO-5 Scores Vary in Moderate-to-Severe Psoriasis Patients Treated with Tildrakizumab 100 mg vs. 200 mg?
Article in Journal of Clinical Medicine (September 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Journal of Clinical Medicine (September 2024)
Article in Biochemical Pharmacology (May 2024)
Article in International Journal of Molecular Sciences (November 2023)